Purification, biochemical and biophysical characterization of lysosomal β-D-glucuronidase from an edible freshwater mussel, Lamellidens corrianus

Preparation of a novel EGFR specific immunotoxin and its efficacy of anti-colorectal cancer in vitro and in vivo

OBJECTIVES

Epithelial growth factor receptor (EGFR), as a malignancy marker, is overly expressed in multiple solid tumors including colorectal neoplasms, one of the most prevalent malignancies worldwide. The main objective of this study is to enhance the efficacy of anti-tumor therapy targeting EGFR by constructing a novel EGFR-specific immunotoxin (C-CUS_245C) based on Cetuximab and recombinant Cucurmosin (CUS_245C).

METHODS

E. coli BL21 (DE3) PlysS (E. coli) was used to express CUS_245C with a cysteine residue inserting to the C-terminus of Cucurmosin. Then immobilized metal ion affinity chromatography (IMAC) was used to purify CUS_245C. The chemical conjugation method was used for the preparation of C-CUS_245C. Then dialysis and IMAC were used to purify C-CUS_245C. Western blot as well as SDS-PAGE was carried out to characterize the formation of C-CUS_245C. At last the anti-colorectal cancer activity of C-CUS_245C was investigated in vitro and in vivo.

RESULTS

CUS_245C with high purity could be obtained from the prokaryotic system. C-CUS_245C was successfully constructed and highly purified. The cytotoxicity assays in vitro showed a significant proliferation inhibition of C-CUS_245C on EGFR-positive cells for 120 h with IC₅₀ values less than 0.1 pM. Besides, the anti-tumor efficacy of C-CUS_245C was remarkably more potent than that of Cetuximab, CUS_245C, and C + CUS_245C (P < 0.001). Whereas the cytotoxicity of C-CUS_245C could hardly be detected on EGFR-null cell line. Our results also showed that C-CUS_245C had efficacy of anti-colorectal cancer in mouse xenograft model, indicating the therapeutic potential of C-CUS_245C for the targeted therapy of colorectal neoplasms.

CONCLUSIONS

C-CUS_245C exhibits potent and EGFR-specific cytotoxicity. Insertional mutagenesis technique is worthy to be adopted in the preparation of immunotoxin. Immunotoxin can be highly purified through dialysis followed by IMAC.

Stabilization of b-Glucuronidase by Immobilization in Magnetic-Silica Hybrid Supports

β-Glucuronidases are a class of enzymes that catalyze the breakdown of complex carbohydrates. They have well documented biocatalytic applications in synthesis, therapeutics, and analytics that could benefit from enzyme immobilization and stabilization. In this work, we have explored a number of immobilization strategies for Patella vulgata β-Glucuronidase that comprised a tailored combination of biomimetic silica (Si) and magnetic nanoparticles (MNPs). The individual effect of each material on the enzyme upon immobilization was first tested. Three different immobilization strategies for covalent attachment on MNPs and different three catalysts for the deposition of Si particles were tested. We produced nine different immobilized preparations and only two of them presented negligible activity. All the preparations were in the micro-sized range (from 1299 ± 52 nm to 2101 ± 67 nm of hydrodynamic diameter). Their values for polydispersity index varied around 0.3, indicating homogeneous populations of particles with low probability of agglomeration. Storage, thermal, and operational stability were superior for the enzyme immobilized in the composite material. At 80 °C different preparations with Si and MNPs retained 40% of their initial activity after 6 h of incubation whereas the soluble enzyme lost 90% of its initial activity within 11 min. Integration of MNPs provided the advantage of reusing the biocatalyst via magnetic separation up to six times with residual activity. The hybrid material produced herein demonstrated its versatility and robustness as a support for β-Glucuronidases immobilization.